Coeptis Therapeutics, Inc. Royalty Expense
Coeptis Therapeutics, Inc. reported Royalty Expense of $166.67 thousand for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RoyaltyExpense · last filed 2021-08-16
- Coeptis Therapeutics, Inc. royalty expense for the quarter ending 2021-06-30 was $166.67K.
- Coeptis Therapeutics, Inc. royalty expense for the quarter ending 2021-03-31 was $250.00K, a 83.33% decline year-over-year.
- Coeptis Therapeutics, Inc. royalty expense for the quarter ending 2020-06-30 was $0.00.
- Coeptis Therapeutics, Inc. royalty expense for the quarter ending 2020-03-31 was $1.50M.
| Period end | Royalty Expense 3 month | Royalty Expense 6 month |
|---|---|---|
| 2021-06-30 | $166.67K 10-Q · filed 2021-08-16 | $416.67K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $250.00K 10-Q/A · filed 2021-05-18 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-16 | $1.50M 10-Q · filed 2021-08-16 |
| 2020-03-31 | $1.50M 10-Q/A · filed 2021-05-18 |